S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION
Harry Gill,
Rita Yim,
Lynn Chin,
Paul Lee,
Vivian LI,
Lester Au,
Man Kit Garret Leung,
Cyrus Kumana,
Yok Lam Kwong
Affiliations
Harry Gill
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Rita Yim
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Lynn Chin
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Paul Lee
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Vivian LI
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Lester Au
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Man Kit Garret Leung
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Cyrus Kumana
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
Yok Lam Kwong
1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong
